Use of thrombin and fibrinogen in skin grafting - Preliminary report
Use of thrombin and fibrinogen in skin grafting - Preliminary report
复制标题
DOI：
10.1001/jama.1944.02850140022006
复制
发表时间：
1944-01-01
影响因子：
--
通讯作者：
Deaver, JM
中科院分区：
文献类型：
--
作者：
Cronkite, EP;Lozner, EL;Deaver, JM
凝血酶和纤维蛋白原的联合使用可增强移植物和受体床的接近。移植的第一阶段几乎是在移植物和受体区域之间形成薄的纤维蛋白粘固剂的瞬间完成的。止血凝血酶控制出血。更少的缝合或有时根本不需要。作者介绍了植皮前后的一般支持治疗，植皮前烧伤的局部处理，凝血酶和纤维蛋白原植皮技术及敷料的应用。本文报告8例。
Approximation of graft and recipient bed is enhanced by the combined use of thrombin and fibrinogen. The first stage of the taking of a graft is consummated almost instantaneously by the formation of a thin fibrin cement between the graft and the recipient area. The hemostatic thrombin controls hemorrhage. Fewer sutures or at times none at all are needed. The authors describe the general supporting treatment of patients before and after skin grafting, the local treatment of burns before grafting, the technic of grafting using thrombin and fibrinogen and the dressing applied. Reports of 8 cases are given.